菲奥·斯基斯托 (FioSchisto) 专家的观点是如何在巴西实施世卫组织关于控制和消除脊髓灰质炎传播的指南
Camilla Almeida Menezes1, Langia Colli Montresor2, Soraya Torres Gaze Jangola2
1Instituto Gonçalo Moniz, Fundação Oswaldo Cruz - FIOCRUZ, Salvador, Brazil.
Frontiers in immunology
|December 25, 2023
概括
消除巴西的石杆菌病需要综合战略,重点关注水,卫生和社区参与. 这种方法符合世卫组织的指导方针,对于流行病地区的公共卫生和疾病控制至关重要.
科学领域:
- 公共卫生 公共卫生
- 热带医学 热带医学
- 传染性疾病 传染性疾病
背景情况:
- 湿病是一种被忽视的热带疾病,目标是到2030年全球消除.
- 巴西的 schistosomiasis mansoni 是一个重要的公共卫生问题,影响弱势群体.
- 世界卫生组织 (WHO) 在2022年发布了新的指导方针,以帮助特有国家控制和消除杆菌病.
研究的目的:
- 在巴西的背景下评估世卫组织对杆菌病的建议的可行性.
- 提出适合巴西流行病学现实的公共卫生政策.
- 为了确定研究需要在巴西推进杆菌病控制.
主要方法:
- 分析世卫组织2022年脊髓灰质炎控制和消除指南.
- 通过奥斯瓦尔多·克鲁兹基金会 (菲奥克鲁兹) 杆菌病翻译计划 (FioSchisto) 的专家咨询和共识建设.
- 审查巴西的流行病学数据和公共卫生基础设施.
主要成果:
- 提供安全的饮用水和卫生设施被确定为巴西消除杆菌病的首要行动.
- 建议采用综合方法,包括初级保健,生态牛控制和信息,教育和通信 (IEC).
- 建议采用两阶段的诊断方法 (免疫学和分子测试) 来监测传输中断.
结论:
- 为了在巴西成功消除杆菌病,需要以社区为中心,跨部门和跨学科的方法.
- 实施需要机构和初级保健团队之间的合作,以流行病学指标为指导.
- 一个强大的信息系统对于决策,监测和战略研究投资至关重要.
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


